Skip to Main Content

Paper Details

A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology
319
2023
MetALD, NAFLD, NASH, Steatotic liver disease, cryptogenic steatotic liver disease, fatty, fatty liver disease, metabolic and alcohol related/associated liver disease, metabolic dysfunction, metabolic dysfunction-associated, patient, steatohepatitis, steatosis, steatotic liver disease
Author NameAffiliation
Arun J SanyalVirginia Commonwealth University
Stephen A HarrisonUniversity of Oxford
Rohit LoombaNAFLD Research Center, University of California at San Diego
Michael RodenMedical Faculty and University Hospital Dusseldorf, Heinrich Heine University Dusseldorf
Michael RodenGerman Center for Diabetes Research
Michael RodenInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Dusseldorf
Miriam B VosEmory University and Children's Healthcare of Atlanta
  • 1 - 7

Datasets

Release 1.2